Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lagevrio
Lagevrio
US plans shift of Merck COVID treatment to commercial market
Reuters
Thu, 10/5/23 - 10:16 am
Merck
COVID-19
Lagevrio
molnupiravir
Merck asks EMA to reevaluate rejected Covid-19 antiviral
Endpoints
Mon, 03/13/23 - 04:40 pm
Merck
Europe
EMA
COVID-19
Lagevrio
molnupiravir
antivirals
Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Tue, 02/21/23 - 04:53 pm
Merck
COVID-19
Lagevrio
clinical trials
Merck pill linked to new mutations, study says
Fierce Pharma
Thu, 02/2/23 - 11:15 pm
Merck
antivirals
COVID-19
Lagevrio
FDA is letting pharmacists prescribe Pfizer's Paxlovid but won't do the same for Merck's Lagevrio
Fierce Pharma
Fri, 07/8/22 - 10:59 am
Pfizer
Merck
Paxlovid
Lagevrio
FDA
pharmacists
COVID-19
Merck makes $3.2bn from COVID-19 drug Lagevrio in Q1
Pharmaforum
Thu, 04/28/22 - 10:48 pm
Merck
earnings
COVID-19
Lagevrio